Effect of Berberine on Expression of Hepatocyte Nuclear Factor-4alpha in Rats with Fructose-induced Insulin Resistance
Overview
Affiliations
The effects of berberine on the expression of hepatocyte nuclear factor-4alpha (HNF-4alpha) in liver of rats with fructose-induced insulin resistance and the molecular mechanism of berberine preventing insulin resistance were investigated. The experimental animals were divided into two groups of 16 animals each. The control group received a control routine diet containing 60% carbohydrate, and the study group a high-fructose diet containing 60% fructose as the sole source of carbohydrate. At the end of 6 weeks these were each subdivided into two groups. One was administered with berberine [187.5 mg/(kg x d) in 5 g/L carboxymethyl cellulose] by intragastric intubation and the other group was treated with a vehicle (5 g/L carboxymethyl cellulose). The rats were fed on the same dietary regimen for the next 4 weeks. After the experimental period of 10 weeks, plasma glucose, insulin and triglyceride levels were measured. HOMA insulin resistance index (HOMA-IR) was assayed. Immunohistochemistry, semiquantitative RT-PCR and western blot were used to detect the expression of HNF-4alpha in liver. Compared with control diet, fructose feeding induced hyperinsulinemia, HOMA-IR and increased triglyceride (all P<0.01). Berberine prevented the rise in plasma insulin (P<0.01), HOMA-IR (P<0.01) and triglyceride (P<0.05) in the fructose-fed rats. No change in plasma glucose was seen among these groups. The mRNA and protein expression of HNF-4alpha was decreased in the fructose-fed rats, but berberine could promote its expression. It was concluded that berberine could prevent fructose-induced insulin resistance in rats possibly by promoting the expression HNF-4alpha in liver.
Li Y, Wang B, Shen J, Bai M, Xu E Pharm Biol. 2020; 58(1):385-392.
PMID: 32393087 PMC: 7269079. DOI: 10.1080/13880209.2020.1756349.
The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes.
Zhao W, Liu Y, Liao X, Zhao S Biomed Res Int. 2020; 2020:3268505.
PMID: 32382544 PMC: 7193279. DOI: 10.1155/2020/3268505.
Hu Q, Li L, Zou X, Xu L, Yi P Front Pharmacol. 2018; 9:1150.
PMID: 30405404 PMC: 6202939. DOI: 10.3389/fphar.2018.01150.
Mohammad Reza S, Hamideh M, Zahra S Evid Based Complement Alternat Med. 2015; 2015:895417.
PMID: 26170888 PMC: 4481084. DOI: 10.1155/2015/895417.
Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice.
Guo Y, Pope C, Cheng X, Zhou H, Klaassen C J Ethnopharmacol. 2011; 138(1):111-8.
PMID: 21920422 PMC: 3384737. DOI: 10.1016/j.jep.2011.08.058.